Catalog No.
EVV03806
Expression system
Mammalian cells
Species
Influenza A virus (A/Darwin/9/2021 (H3N2))
Protein length
Ala16-Asp529
Predicted molecular weight
64.73 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
WEY08928.1
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Hemagglutinin, HA
Tuning the Aggregation of Plasmonic Probes to Shed Light on Diagnostic Strategies., PMID:40504768
Inhibition of Influenza Entry by Organosilicon Compounds., PMID:40492611
Label-Free Detection of Virus-Membrane Interactions Using Surface-Enhanced Infrared Absorption (SEIRA) Spectroscopy., PMID:40489072
Genetic diversity of H9N2 avian influenza viruses in poultry across China and implications for zoonotic transmission., PMID:40461649
No indication of highly pathogenic avian influenza infections in Dutch cows., PMID:40458141
hnRNPM regulates influenza A virus replication through distinct mechanisms in human and avian cells: implications for cross-species transmission., PMID:40434105
Phylogenetic Analysis and Spread of HPAI H5N1 in Middle Eastern Countries Based on Hemagglutinin and Neuraminidase Gene Sequences., PMID:40431745
A G219A hemagglutinin substitution increases pathogenicity and viral replication of Eurasian avian-like H1N1 swine influenza viruses., PMID:40408884
DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivo., PMID:40398322
A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface., PMID:40391889
Shared host genetic landscape of respiratory viral infection., PMID:40372436
Emergence of Antigenic Variants in Bovine H5N1 Influenza Viruses., PMID:40365787
Influenza virus: Genomic insights, evolution, and its clinical presentation., PMID:40345348
Impact of age and prior COVID-19 on the response to influenza a components in the 2020-2021 Fluzone vaccine., PMID:40328185
Unique phenomenon of H5 highly pathogenic avian influenza virus in China: co-circulation of Clade 2.3.4.4b H5N1 and H5N6 results in diversity of H5 Virus., PMID:40326336
Influenza A(H1N1)pdm09 virus resistance to baloxavir, oseltamivir and sialic acid mimetics in single and dual therapies: Insights from human airway epithelia and murine models., PMID:40324597
Multiple antiviral mechanisms of Ephedrae Herba and Cinnamomi Cortex against influenza: inhibition of entry and replication., PMID:40304468
Molecular and In Vivo Characterization of the High Pathogenicity H7N6 Avian Influenza Virus That Emerged in South African Poultry in 2023., PMID:40303135
Effects of the Glycosylation of the HA Protein of H9N2 Subtype Avian Influenza Virus on the Pathogenicity in Mice and Antigenicity., PMID:40303068
An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses., PMID:40301359
Influenza B viruses are more susceptible to high temperatures than influenza A viruses., PMID:40295766
Chimeric virus-like particles of nodavirus displaying M2e of human and avian influenza A viruses as a potential dual-use vaccine: Inducing a broader immune response and protecting mice against viral infections., PMID:40286563
Sulfatide Binds to Influenza B Virus and Enhances Viral Replication., PMID:40284974
The Ongoing Epidemics of Seasonal Influenza A(H3N2) in Hangzhou, China, and Its Viral Genetic Diversity., PMID:40284969
Comparative Mutational Analysis and the Glycosylation Patterns of a Peruvian Isolated Avian Influenza A Virus H5N1: Exploring Possible Viral Spillover Events Within One Health Approach., PMID:40284894
The bat influenza A virus subtype H18N11 induces nanoscale MHCII clustering upon host cell attachment., PMID:40280957
Multivalent H3 COBRA-based influenza vaccine elicits enhanced immune response in a pre-immune elderly ferret model., PMID:40267617
Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies., PMID:40267182
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination., PMID:40265888
Antibody function predicts viral control in newborn monkeys immunised with an influenza virus HA stem nanoparticle., PMID:40263387
Glucosidase alpha neutral C promotes influenza virus replication by inhibiting proteosome-dependent degradation of hemagglutinin., PMID:40263249
Risk assessment of 2024 cattle H5N1 using age-stratified serosurveillance data., PMID:40262547
Evolutionary dynamics and molecular epidemiology of H1N1 pandemic 2009 influenza A viruses across swine farms in Denmark., PMID:40235651
The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors., PMID:40232794
Influenza A hemagglutinin virus-like particles confer protection against influenza B virus infection., PMID:40230200
Emergence of influenza A(H1N1)pdm09 6B.1A.5a.2a and 6B.1A.5a.2a.1 subclades leading to subtyping failure in a commercial molecular assay., PMID:40220733
Cell binding, uptake, and infection of influenza A virus using recombinant antibody-based receptors., PMID:40207931
Avian influenza A(H5N6) virus detected during live-poultry market surveillance linked to a human infection in Changsha, China, from 2020 to 2023., PMID:40205236
A paper-based loop-mediated isothermal amplification assay for highly pathogenic avian influenza., PMID:40204842
Isoxazole and Pyrazole Derivatives of 28-Oxo-Allobetulone Target Viral Membrane Glycoprotein Hemagglutinin., PMID:40195084
De novo design and discovery of broad-spectrum affinity peptide ligands for influenza A vaccines., PMID:40194500
A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses., PMID:40193611
Immunogenicity and protective efficacy of an inactivated bivalent vaccine containing two recombinant H1N1 and H3N2 swine influenza virus strains., PMID:40192841
Identification and characterization of a broadly neutralizing and protective nanobody against the HA1 domain of H5 avian influenza virus hemagglutinin., PMID:40192291
Machine learning methods for predicting human-adaptive influenza A virus reassortment based on intersegment constraint., PMID:40190733
Live-attenuated pandemic H1N1 influenza vaccines expressing computationally optimized broadly reactive antigens (COBRAs) are immunogenic and protective in mice and ferrets., PMID:40186991
Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody., PMID:40178595
Neutralizing monoclonal antibodies as effective therapeutics and prophylactics against lethal H10N7 avian influenza infection in a mouse model., PMID:40176109
Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus., PMID:40145257
Tracking Seasonal Influenza Trends in South Tyrol During 2022/2023 Using Genomic Surveillance Data., PMID:40143444
For research use only. Not for human or drug use.
